Global Brand Lead Rilzabrutinib - Global Launch Center

Lead the Global Brand Team (GBT), responsible for the development of brand strategy and ensuring consistent global execution. GBT is comprised of senior leaders from key markets and functions, including Commercial, Medical, Regulatory, Development, Legal, M&S; and Supply Chain. Commercial Chair on Global Product Team (GPT). GPT serves as the central cross-functional governance body responsible for strategic oversight and coordination of a product's development journey from early-stage research through commercialization. Chaired by Product Development leadership, this team integrates expertise across R&D;, commercial, medical, regulatory, manufacturing, and other critical functions to ensure aligned decision-making and seamless execution of the product strategy. Develop the commercial ambition for the brand (short, mid, and long term) and deploy strategies to achieve business goals; act as the primary internal "champion" for WAYRILZ (Rilzabrutinib) and represent the brand in presentations to senior management. Partner with Global Medical and HEVA on the development of Scientific Key Message platform. Provide input into Scientific Communications planning for publication strategy and brand awareness generation. Partner with Global Market research to ensure a robust execution of launch foundation insight generation, including a demand study, competitive TPP, market map, HCP and patient segmentation, treatment journey, patient journey including both diagnosis and treatment journey, HCP needs and drivers, patient need and drivers. Partner with New Product Planning on the development of the Therapeutic Area Strategy Narrative and support brand Life Cycle Management (LCM) development. This includes the future indications of wAIHA and CVID. Articulate a clear brand strategy, create a brand narrative, and align the organization to it. In partnership with Wave 1 launch markets and Global Rare Commercialization Team, lead the creation of launch business cases, identify the ideal market shaping plan, work with countries and Medical Affairs to execute it and measure effectiveness through pre-determined KPIs. In partnership with Franchise Launch Excellence (FLEX), incorporate WAYRILZ (Rilzabrutinib) strategies with the Sanofi Integrated Launch Capabilities (SILC) to enable launch simulation and scenario planning. Lead preparation for launch and ensure all elements of the plan are designed, high quality, and executed with precision. In partnership with GTMC (Go To Market Capabilities) Omnichannel, develop a multichannel strategy/approach to amplify the WAYRILZ (Rilzabrutinib) experience including go-to-market and omnichannel rollout. Achieve sales, profit, and market share within agreed budgets. Monitor and review business performance and ensure management action adhere to agreed plans. Manage budget to highest impact opportunities. Ensure operational efficiency and effectiveness of all aspects of the business. Build a best-in-class marketing team while cultivating an inclusive high-performance environment that values and leverages diversity. Provide personal leadership to inspire and motivate marketing teams, country teams, and functional partners to continuously strive for excellence. Attract, select, and develop key talent and ensure retention of high performers. Strengthen the team and the company by creating a winning spirit and by developing excellence-oriented and customer-focused culture.

Sanofi International AG, based in Switzerland, is establishing a new transformational global commercialization center— at the cornerstone of Sanofi "Launch Powerhouse" strategy. We are building a new world-class, centralized launch engine designed to orchestrate end-to-end commercialization for breakthrough medicines and vaccines across our Immunology and Specialty Care portfolios, that will reinforce and strengthen Sanofi’s existing launch expertise and network. This is not a traditional pharmaceutical role. You will be part of a new pioneering, entrepreneurial entity with real decision-making authority over global launch strategies, pricing corridors, market access, lifecycle management, manufacturing, supply chain, and commercial execution. Working alongside a diverse, cross-functional team of approximately 150 dedicated professionals co-located in Switzerland, you will drive standardized, data-driven, AI-powered launch excellence at unprecedented scale. Success in this role requires seamless, daily collaboration across medical affairs, commercial strategy, regulatory, manufacturing & supply, market access, and digital teams. By working together in one location, we eliminate silos, accelerate decision-making, foster innovation through continuous coordination, and create the agility needed to transform patient access worldwide. This is where strategy meets execution—where your work directly impacts millions of patients awaiting our next generation of therapies.

• Undergraduate degree in business, science, or related discipline required; advanced degree (MD or MBA) preferred.

• A Seasoned and well-rounded leader with at least 10 years of demonstrated success in marketing, launches, and general management roles of progressively greater scope and responsibility, including in Global and the US.

• Experience building and leading a pharmaceutical/biotech commercial organization with marketing responsibilities and successful general management experience preferred.

• Demonstrated success in commercial planning, launching, aggressively growing, and managing products through their life cycle.

• A demonstrated commitment to innovation and experience leading significant transformational change.

• Proven skills in communicating changes, managing design and implementation, applying innovative thinking, and aligning plans, people, and processes.

• Experience working collaboratively and cross-functionally with marketing brand teams, market research, sales, managed markets, sales operations, medical affairs, business development, regulatory, R&D;, manufacturing, finance, and legal.

• Experience in ITP (Immune Thrombocytopenia), wAIHA (Warm Autoimmune Hemolytic Anemia), CVID (Common Variable Immunodeficiency), and/or relevant rare disease experience preferred.

• Strategic agility: analytic and synthetic capacity with the ability to generate actionable insights that create a competitive advantage or opens new markets; ability to chart a path and get from strategy to execution successfully.

• Organizational, interpersonal, and communication skills demonstrated at an advanced level.

• Ability to lead in an ambiguous environment across different functions and company cultures.

• Performance orientation and ability to work and deliver along agreed timelines.

• Team leadership skills with proven ability to develop next generation leaders.

• Ability to work with, motivate, and develop diverse and high-performing teams.

• Customer focus and understanding of how customers perceive their business relative to competition.